Multiple myeloma: open trials in Brazil

24 open trials have a site in Brazil. Registry data; only the trial team decides who can take part.

NCT07222761
A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
Trial Treatment · Phase 3 · Regeneron Pharmaceuticals
Cetus Oncologia, Belo Horizonte · Hospital Erasto Gaertner, Curitiba · Centro de Hematologia e Oncologia, Joinville · ANIMI, Lages · Oncomed Clínica Oncológica, Niterói · Centro Gaúcho Integrado - Hospital Mae de Deus, Porto Alegre · Hospital de Clinicas de Porto Alegre, Porto Alegre · Unidade de Pesquisa Clinica (UPC); Hospital das Clinicas de Ribeirao Preto da Universidade de Sao Paulo, Ribeirão Preto · AC Camargo Cancer Center, São Paulo · Clinica Medica Sao Germano, São Paulo
Registry updated 2026-11-04
NCT05552222
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Fundacao Pio XII, Barretos · Santa Casa de Misericordia de Belo Horizonte, Belo Horizonte · Hospital Erasto Gaertner - Liga Paranaense de Combate ao Câncer, Curitiba · Instituto do Câncer do Ceará, Fortaleza · Liga Norte Riograndense Contra o Cancer, Natal · Complexo Hospitalar de Niteroi, Niterói · Hospital de Clinicas de Porto Alegre, Porto Alegre · Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto, Ribeirão Preto · IDOR - Regional Bahia, Salvador · Clinica Medica Sao Germano LTDA, São Paulo · Hospital Nove de Julho, São Paulo · Hospital das Clinicas da Faculdade de Medicina da USP, São Paulo
Registry updated 2026-11-03
NCT07258511
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Hospital das Clinicas da Universidade Estadual de Campinas UNICAMP, Campinas · Fundacao Universidade de Caxias Do Sul, Caxias do Sul · Hospital Erasto Gaertner - Liga Paranaense de Combate ao Câncer, Curitiba · Grupo ELORA Centro de Pesquisa e Ensino em Saude de Santa Catarina, Florianópolis · Instituto de Educacao, Pesquisa e Gestao em Saude Instituto Americas (COI), Rio de Janeiro · IDOR - Regional Bahia, Salvador · Funfarme Sjrp, São José do Rio Preto · IDOR - Regional Sao Paulo, São Paulo · Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein, São Paulo · Fundacao Antonio Prudente A C Camargo Cancer Center, São Paulo · Clinica Medica Sao Germano LTDA, São Paulo
Registry updated 2026-11-03
NCT05519085
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
Trial Treatment · Phase 3 · Celgene
Jaú · Joinville · Porto Alegre · Rio de Janeiro · Salvador · São Paulo · São Paulo
Registry updated 2026-10-30
NCT06106945
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
Trial Treatment · Phase 1/2 · AstraZeneca
Salvador · São Paulo
Registry updated 2026-10-30
NCT06615479
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
Trial Treatment · Phase 3 · Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Nova Lima · Instituto D'Or de Pesquisa e Ensino (IDOR), São Paulo · A.C. Camargo Cancer Center, São Paulo · Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein, São Paulo
Registry updated 2026-10-29
NCT05623020
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
Trial Treatment · Phase 3 · Pfizer
Centro Gaucho Integrado de Oncologia, Hematologia, Ensino e Pesquisa, Porto Alegre · Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (USP), Ribeirão Preto
Registry updated 2026-10-27
NCT04973605
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
Trial Treatment · Phase 1/2 · BeOne Medicines
Instituto Dor de Pesquisa E Ensino Distrito Federal, Brasília · Hospital Sirio Libanes Brasilia, Brasília · Centro Gaucho Integrado de Oncologia Hospital Mae de Deus, Porto Alegre · Hospital Sao Rafael (Rede Dor), Salvador · Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein, São Paulo · Instituto Dor de Pesquisa E Ensino Sao Paulo, São Paulo · Hospital Sirio Libanes, São Paulo
Registry updated 2026-10-26
NCT07735637
A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6).
Trial Treatment · Phase 3 · AstraZeneca
Salvador · São Paulo
Registry updated 2026-10-21
NCT05669989
International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab
Trial Treatment · Phase 2 · Sanofi
Hospital Mae de Deus- Site Number : 0760003, Porto Alegre · Instituto Americas - Ensino, Pesquisa e Inovação - Rio de Janeiro - Avenida Jorge Curi- Site Number : 0760001, Rio de Janeiro · Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo- Site Number : 0760002, São Paulo
Registry updated 2026-10-15
NCT06980480
A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma
Trial Treatment · Phase 3 · Takeda
Centro de Hematologia e Oncologia (CHO), Joinville · Sao Jose do Rio Preto Regional Faculty of Medicine FoundationSao Jose do Rio Preto Regional Faculty of Medicine Foundation, Porto Alegre · Instituto Oncoclínicas de Ensino, Rio de Janeiro · Instituto D'Or de Pesquisa e Ensino, Salvador · Instituto D'Or de Pesquisa E Ensino - São Paulo, São Paulo
Registry updated 2026-10-13
NCT07555938
Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma
Trial Treatment · Phase 3 · Hoffmann-La Roche
Hospital Israelita Albert Einstein, São Paulo
Registry updated 2026-10-13
NCT05243797
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
Trial Treatment · Phase 3 · European Myeloma Network B.V.
Hospital Mãe de Deus - Centro Integrado de Oncologia, Porto Alegre · Hospital Santa Rita, Porto Alegre · Instituto Americas de Ensino,Pesquisa e Inovação, Rio de Janeiro · IDOR- Instituto D'or de pesquisa. Av. São Rafael, Salvador · Hcor, Associacao Siria, São Paulo · A Real e Benemérita Associação Portuguesa de Beneficência, São Paulo · Universidade Federal de São Paulo - Hospital São Paulo, São Paulo · Hemocentro UNICAMP, Universidade Estadual de Campinas, São Paulo · Departamento de Oncologia Clínica AC Camargo Cancer Center, São Paulo · Grupo Oncoclínicas Pesquisa Clínica, São Paulo · Hospital Paulistano, Centro de Pesquisa Clinica R. Martiniano de Carvalho, São Paulo · Hospital das Clínicas da Universidade de São Paulo, São Paulo · Clínica Medica São Germano,Grupo Oncoclínicas Pesquisa Clínica, São Paulo · Onco Star, São Paulo
Registry updated 2026-10-07
NCT05730036
A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma
Trial Treatment · Phase 3 · Regeneron Pharmaceuticals
Associacao Dr. Bartholomeu Tacchini, Bento Gonçalves · Hospital Erasto Gaertner, Curitiba · ANIMI - Unidade de Tratamento Oncológico, Lages · Centro Gaucho Integrado, Porto Alegre · Hospital de Clinicas de Porto Alegre, Porto Alegre · Instituto Americas de Ensino e Pesquisa, Rio de Janeiro · IDOR - Sao Rafael Salvador Bahia, Salvador · AC Camargo Cancer Center, São Paulo · A Beneficencia Portuguesa de Sao Paulo, Oncology House, São Paulo · Instituto Dor de Pesquisa E Ensino, São Paulo · Clinica Medica Sao Germano, São Paulo
Registry updated 2026-10-07
NCT07391657
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
Trial Treatment · Phase 3 · AstraZeneca
Salvador · São Paulo
Registry updated 2026-09-29
NCT06500884
A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events
Trial Treatment · Phase 2 · Janssen Research & Development, LLC
IDOR - Regional Brasilia, Brasília · Fundacao Universidade de Caxias Do Sul, Caxias do Sul · Hospital Erasto Gaertner - Liga Paranaense de Combate ao Câncer, Curitiba · IDOR - Regional Bahia, Salvador · Clinica Medica Sao Germano LTDA, São Paulo · IDOR - Regional Sao Paulo, São Paulo
Registry updated 2026-09-25
NCT07518186
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Sociedade Beneficente de Senhoras - Hospital Sirio Libanes HSL Unidade Brasilia, Brasília · Hospital Erasto Gaertner - Liga Paranaense de Combate ao Câncer, Curitiba · Grupo ELORA Centro de Pesquisa e Ensino em Saude de Santa Catarina, Florianópolis · Instituto Joinvilense de Hematologia e Oncologia Ltda Centro de Hematologia e Oncologia, Joinville · Irmandade Santa Casa de Misericordia de Porto Alegre, Porto Alegre · Instituto de Educacao, Pesquisa e Gestao em Saude Instituto Americas (COI), Rio de Janeiro · Funfarme Sjrp, São José do Rio Preto · Real e Benemerita Associacao Portuguesa de Beneficencia, São Paulo · Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein, São Paulo · Clinica Medica Sao Germano LTDA, São Paulo
Registry updated 2026-09-25
NCT05020236
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
Trial Treatment · Phase 3 · Pfizer
Centro de Pesquisa Clínica - Área Administrativa, Porto Alegre · Hospital Mae de Deus, Porto Alegre · Centro Gaucho Integrado de Oncologia, Hematologia, Ensino e Pesquisa, Porto Alegre · Instituto de Educacao Pesquisa e Gestao em Saude, Rio de Janeiro · Hospital Américas Medical City, Rio de Janeiro · Instituto D'Or de Pesquisa e Ensino (IDOR) - Filial Salvador, Salvador · BP - A Beneficência Portuguesa de São Paulo, São Paulo · ESHO Empresa de Serviços Hospitalares S.A/ Hospital Samaritano de Higienópolis, São Paulo · Clínica Médica São Germano S/S Ltda, São Paulo · Instituto D'Or de Pesquisa e Ensino (IDOR), São Paulo · Universidade Federal de Sao Paulo, São Paulo · IDOR Ensino e Pesquisa, São Paulo · HU UNIFESP / SPDM - Hospital São Paulo, São Paulo · Clínica Médica São Germano LTDA, SP
Registry updated 2026-08-24
NCT06152575
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Trial Treatment · Phase 3 · Pfizer
Hospital Amaral Carvalho, Jaú · Oncomed Clínica Oncológica, Niterói · Instituto Oncomed de Educação e Pesquisa, Niterói · Centro Gaucho Integrado de Oncologia, Hematologia, Ensino e Pesquisa, Porto Alegre · Hospital Mae de Deus, Porto Alegre · Hospital Moinhos de Vento, Porto Alegre · Centro de Pesquisa Clínica - Área Administrativa, Porto Alegre · Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (USP), Ribeirão Preto · Americas Centro de Oncologia Integrado, Rio de Janeiro · Instituto de Educacao Pesquisa e Gestao em Saude, Rio de Janeiro · Instituto D'Or de Pesquisa e Ensino (IDOR) - Filial Salvador, Salvador · Clínica Médica São Germano S/S Ltda, São Paulo · HU UNIFESP / SPDM - Hospital São Paulo, São Paulo · Instituto D'Or de Pesquisa e Ensino (IDOR), São Paulo · Universidade Federal de Sao Paulo, São Paulo · ESHO Empresa de Serviços Hospitalares S.A/ Hospital Samaritano de Higienópolis, São Paulo · Clínica Médica São Germano LTDA, SP
Registry updated 2026-08-24
NCT05714839
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
Trial Treatment · Phase 1/2 · GlaxoSmithKline
Joinville · Salvador · São Paulo
Registry updated 2026-08-19
NCT07764978
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
Trial Treatment · Phase 3 · AstraZeneca
Salvador · São Paulo
Registry updated 2026-08-14
NCT06679101
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
Trial Treatment · Phase 3 · GlaxoSmithKline
Barretos · Joinville · Porto Alegre · Salvador · São Paulo · Teresina · Vitória
Registry updated 2026-04-22
NCT07268846
Use of Preoperative Postbiotic Supplementation in Colorectal Cancer Surgery
Trial Treatment · AC Camargo Cancer Center
A.C. Camargo Cancer Center, São Paulo
Registry updated 2025-12-08
NCT06787807
Proteomic Analysis of Patients Undergoing Bariatric Surgery
Trial Treatment · Universidade Federal de Pernambuco
Hospital das clínicas da UFPE, Recife
Registry updated 2025-01-22

All Multiple myeloma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error